Bernard Wealth Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.32K Hold
50
﹤0.01% 245
2026
Q1
$6.97K Hold
50
﹤0.01% 243
2025
Q4
$6.14K Hold
50
﹤0.01% 236
2025
Q3
$5.55K Hold
50
﹤0.01% 235
2025
Q2
$5.54K Sell
50
-13
-21% -$1.38K ﹤0.01% 233
2025
Q1
$7.06K Sell
63
-112
-64% -$11.6K ﹤0.01% 239
2024
Q4
$16.2K Buy
+175
New +$15.8K 0.01% 193

Other funds holding GILD

Bernard Wealth Management's GILD Position: Q2 2026 in Review

Bernard Wealth Management held its Gilead Sciences (GILD) position steady in Q2 2026 at 50 shares worth $6.32K. The position accounts for ﹤0.01% of the portfolio, ranked #245.

Bernard Wealth Management first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. The position peaked at $16.2K in Q4 2024. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Bernard Wealth Management held 50 shares of Gilead Sciences worth $6.32K as of Q2 2026.
  • Bernard Wealth Management left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up ﹤0.01% of Bernard Wealth Management's portfolio in Q2 2026, its #245 holding.
  • Bernard Wealth Management first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
  • Bernard Wealth Management's Gilead Sciences position peaked at $16.2K in Q4 2024.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Bernard Wealth Management's 13F filing for Q2 2026, filed 21 Aug 2026.